Biosynex SA 13D and 13G filings for Chembio Diagnostics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-01 09:21 am Purchase |
2023-04-27 | 13D | Chembio Diagnostics, Inc. CEMI |
Biosynex SA | 37,059,993 100.000% |
37,059,993 (New Position) |
Filing |